These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 20703849)

  • 21. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
    Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
    Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis.
    Triantafyllou T; Aggarwal P; Gupta E; Svetanoff WJ; Bhirud DP; Singhal S
    J Laparoendosc Adv Surg Tech A; 2018 Jul; 28(7):867-879. PubMed ID: 29356589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts.
    Weber CN; Nadolski GJ; White SB; Clark TW; Mondschein JI; Stavropoulos SW; Shlansky-Goldberg RD; Trerotola SO; Soulen MC
    J Vasc Interv Radiol; 2015 Sep; 26(9):1257-65; quiz 1265. PubMed ID: 25990133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis.
    Cejna M; Peck-Radosavljevic M; Thurnher SA; Hittmair K; Schoder M; Lammer J
    Radiology; 2001 Nov; 221(2):437-46. PubMed ID: 11687688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency.
    Jirkovsky V; Fejfar T; Safka V; Hulek P; Krajina A; Chovanec V; Raupach J; Lojik M; Vanasek T; Renc O; Ali SM
    J Vasc Interv Radiol; 2011 Jan; 22(1):55-60. PubMed ID: 21106389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J; Kroencke TJ; Schuetz T; Plauth M; Kasim E; Petersein J; Schmidt HH; Lochs H
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Geeroms B; Laleman W; Laenen A; Heye S; Verslype C; van der Merwe S; Nevens F; Maleux G
    Eur Radiol; 2017 May; 27(5):1795-1803. PubMed ID: 27629421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents.
    Pan JJ; Chen C; Geller B; Firpi R; Machicao VI; Caridi JG; Nelson DR; Morelli G
    Clin Radiol; 2008 Oct; 63(10):1142-8. PubMed ID: 18774362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The retrospective study of transjugular intrahepatic portosystemic shunt with covered or uncovered stents in patients with portal hypertension].
    Wu XJ; Cao JM; Han JM; Huang Q; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):83-7. PubMed ID: 20302722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
    Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanded PTFE-covered stent-grafts in the treatment of transjugular intrahepatic portosystemic shunt (TIPS) stenoses and occlusions.
    Echenagusia M; Rodriguez-Rosales G; Simo G; Camuñez F; Bañares R; Echenagusia A
    Abdom Imaging; 2005; 30(6):750-4. PubMed ID: 16245017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.
    Gandini R; Konda D; Simonetti G
    Radiology; 2006 Oct; 241(1):298-305. PubMed ID: 16908675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts.
    Haskal ZJ
    Radiology; 1999 Dec; 213(3):759-66. PubMed ID: 10580950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience.
    Buechter M; Manka P; Gerken G; Canbay A; Blomeyer S; Wetter A; Altenbernd J; Kahraman A; Theysohn JM
    Dig Dis; 2018; 36(3):218-227. PubMed ID: 29316565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y; Guo T
    Acad Radiol; 2019 Feb; 26(2):188-195. PubMed ID: 29934023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience.
    Gupta AC; Wang W; Shah C; Sands MJ; Bullen J; Remer EM; Bayona PM; Carey W; Kapoor B
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1723-1731. PubMed ID: 28512687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.